Search Results - "Postma, TJ"

Neurotoxic complications of chemotherapy in patients with cancer: Clinical signs and optimal management by VERSTAPPEN, Carla C. P, HEIMANS, Jan J, HOEKMAN, Klaas, POSTMA, Tjeerd J

“…Neurotoxic side effects of chemotherapy occur frequently and are often a reason to limit the dose of chemotherapy. Since bone marrow toxicity, as the major…”
Get full text

Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study by Klein, M, Heimans, JJ, Aaronson, NK, van der Ploeg, HM, Grit, J, Muller, M, Postma, TJ, Mooij, JJ, Boerman, RH, Beute, GN, Ossenkoppele, GJ, van Imhoff, GW, Dekker, AW, Jolles, J, Slotman, BJ, Struikmans, H, Taphoorn, MJB

“…Because survival benefits of treatment with radiotherapy are questionable and such treatment can cause substantial damage to the brain over time, the optimum…”
Get full text

Long term effects of vincristine on the peripheral nervous system by POSTMA, T. J, BENARD, B. A, HUIJGENS, P. C, OSSENKOPPELE, G. J, HEIMANS, J. J

“…Forty patients with Non-Hodgkin's Lymphoma treated with vincristine between 1984 and 1990 (cumulative dose 12 mg in 18-24 weeks) were investigated in order to…”
Get full text

The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20 by Postma, T.J., Aaronson, N.K., Heimans, J.J., Muller, M.J., Hildebrand, J.G., Delattre, J.Y., Hoang-Xuan, K., Lantéri-Minet, M., Grant, R., Huddart, R., Moynihan, C., Maher, J., Lucey, R.

“…Chemotherapy-induced peripheral neuropathy (CIPN) is a common phenomenon, often resulting in serious limitations in daily functioning and comprosised quality…”
Get full text

Epilepsy in low-grade gliomas: The impact on cognitive function and quality of life by Klein, Martin, Engelberts, Nadine H. J., van der Ploeg, Henk M., Kasteleijn-Nolst Trenité, Dorotheé G. A., Aaronson, Neil K., Taphoorn, Martin J. B., Baaijen, Hans, Vandertop, W. Peter, Muller, Martin, Postma, Tjeerd J., Heimans, Jan J.

“…Low‐grade gliomas frequently are associated with epilepsy. The purpose of this study is to determine the impact of epilepsy and antiepileptic drug (AED)…”
Get full text

Dose-related vincristine- induced peripheral neuropathy with unexpected off-therapy worsening by VERSTAPPEN, C. C. P, KOEPPEN, S, HEIMANS, J. J, HUIJGENS, P. C, SCHEULEN, M. E, STRUMBERG, D, KIBURG, B, POSTMA, T. J

“…This study describes the natural course of vincristine-induced peripheral neuropathy in patients with lymphoma (n = 114) receiving vincristine in two different…”
Get full text

How do brain tumors alter functional connectivity? A magnetoencephalography study by Bartolomei, Fabrice, Bosma, Ingeborg, Klein, Martin, Baayen, Johannes C., Reijneveld, Jaap C., Postma, Tjeerd J., Heimans, Jan J., van Dijk, Bob W., de Munck, Jan C., de Jongh, Arent, Cover, Keith S., Stam, Cornelis J.

“…Objective This study was undertaken to test the hypothesis that brain tumors interfere with normal brain function by disrupting functional connectivity of…”
Get full text

Rasch-Transformed Total Neuropathy Score clinical version (RT-TNSc©) in patients with chemotherapy-induced peripheral neuropathy by Binda, Davide, Cavaletti, Guido, Cornblath, David R., Merkies, Ingemar S. J.

“…Composite scales such as the Total Neuropathy Score clinical version (TNSc©) have been widely used to measure neurological impairment in a standardized manner…”
Get full text

Grading of chemotherapy-induced peripheral neuropathy by Postma, T. J., Heimans, J. J.

Get full text

Childhood brain tumours due to germline bi-allelic mismatch repair gene mutations by Johannesma, PC, van der Klift, HM, van Grieken, NCT, Troost, D, te Riele, H, Jacobs, MAJM, Postma, TJ, Heideman, DAM, Tops, CMJ, Wijnen, JT, Menko, FH

“…Johannesma PC, van der Klift HM, van Grieken NCT, Troost D, te Riele H, Jacobs MAJM, Postma TJ, Heideman DAM, Tops CMJ, Wijnen JT, Menko FH. Childhood brain…”
Get full text

The prognostic value of cognitive functioning in the survival of patients with high-grade glioma by KLEIN, M, POSTMA, T. J, TAPHOORN, M. J. B, AARONSON, N. K, VANDERTOP, W. P, MULLER, M, VAN DER PLOEG, H. M, HEIMANS, J. J

“…The authors studied cognitive functioning as a potential predictor of survival in 68 newly diagnosed patients with high-grade glioma. In a combined Cox…”
Get full text

Interobserver variability in the radiological assessment of response to chemotherapy in glioma by VOS, M. J, UITDEHAAG, B. M. J, BARKHOF, F, HEIMANS, J. J, BAAYEN, H. C, BOOGERD, W, CASTELIJNS, J. A, ELKHUIZEN, P. H. M, POSTMA, T. J

“…To assess the interobserver variability in the radiologic assessment of response to chemotherapy in patients with recurrent glioma. Five clinicians with…”
Get full text

Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy by Postma, T. J., Heimans, J. J., Muller, M. J., Ossenkoppele, G. J., Vermorken, J. B., Aaronson, N. K.

“…Background Reliable reporting of chemotherapy-induced neurotoxicity is important. The objectives of the current study were to evaluate the differences in the…”
Get full text

Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma by POSTMA, T. J, KLEIN, M, AARONSON, N. K, HEIMANS, J. J, VERSTAPPEN, C. C. P, BROMBERG, J. E. C, SWENNEN, M, LANGENDIJK, J. A, TAPHOORN, M. J. B, SCHELTENS, P, SLOTMAN, B. J, VAN DER PLOEG, H. M

“…Abnormalities on CT or MRI and neuropsychological performance in patients with low-grade glioma, with (n = 23) or without (n = 16) prior cerebral radiotherapy,…”
Get full text

Paclitaxel-induced neuropathy by Postma, T J, Vermorken, J B, Liefting, A J, Pinedo, H M, Heimans, J J

“…Paclitaxel (Taxol) is a new antineoplastic agent derived from the bark of the western yew, Taxus brevifolia, with important activity against several tumors…”
Get more information

PCV chemotherapy for recurrent glioblastoma multiforme by KAPPELLE, A. C, POSTMA, T. J, TAPHOORN, M. J. B, GROENEVELD, G. J, VAN DEN BENT, M. J, VAN GROENINGEN, C. J, ZONNENBERG, B. A, SNEEUW, K. C. A, HEIMANS, J. J

“…The authors evaluated response, time to progression (TTP), survival, prognostic factors, and toxicity in 63 patients with a recurrent glioblastoma multiforme…”
Get full text

Radiologic findings in patients treated with boron neutron capture therapy for glioblastoma multiforme within EORTC trial 11961 by Vos, Maaike J, Turowski, Bernd, Zanella, Friedhelm E, Paquis, Philippe, Siefert, Axel, Hideghéty, Katalin, Haselsberger, Klaus, Grochulla, Frank, Postma, Tjeerd J, Wittig, Andrea, Heimans, Jan J, Slotman, Ben J, Vandertop, W Peter, Sauerwein, Wolfgang

“…To assess the occurrence and development of cerebral radiologic changes (cerebral atrophy and white matter lesions) in patients treated with boron neutron…”
Get more information

Delayed radiation toxicity after focal or whole brain radiotherapy for low-grade glioma by SWENNEN, M. H. J, BROMBERG, J. E. C, WITKAMP, Th. D, TERHAARD, C. H. J, POSTMA, T. J, TAPHOORN, M. J. B

“…To evaluate the influence of radiation volume and other risk factors for the development of delayed radiation toxicity in patients treated for low-grade…”
Get full text

Thallium-201 Single-Photon Emission Computed Tomography As an Early Predictor of Outcome in Recurrent Glioma by VOS, Maaike J, HOEKSTRA, Otto S, BARKHOF, Frederik, BERKHOF, Johannes, HEIMANS, Jan J, VAN GROENINGEN, Cees J, VANDERTOP, W. Peter, SLOTMAN, Ben J, POSTMA, Tjeerd J

“…With limited response rates and potential toxicity of chemotherapeutic treatment in patients with recurrent glioma, reliable response assessment is essential…”
Get full text

Amifostine Protects Against Chemotherapy-induced Neurotoxicity: An In Vitro Investigation by VERSTAPPEN, Carla C. P, POSTMA, Tjeerd J, GELDOF, Albert A, HEIMANS, Jan J

“…Background: Peripheral neurotoxicity is a dose-limiting side-effect of a number of effective chemotherapeutic agents. Neuroprotective agents may help to reduce…”
Get full text